The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
The molecular mechanisms that control thrombopoiesis
Open accessAbstract
Our understanding of thrombopoiesis -the formation of blood platelets -has improved greatly in the last decade, with the cloning and characterization of thrombopoietin, the primary regulator of this process.Thrombopoietin affects nearly all aspects of platelet production, from self-renewal and expansion of HSCs, through stimulation of the proliferation of megakaryocyte progenitor cells, to support of the maturation of these cells into platelet-producing cells.The molecular and cellular mechanisms through which thrombopoietin affects platelet production provide new insights into the interplay between intrinsic and extrinsic influences on hematopoiesis and highlight new opportunities to translate basic biology into clinical advances. Overview of platelets and thrombopoiesisAn adequate supply of platelets is essential to repair the minute vascular damage that occurs with daily life, and to initiate thrombus formation in the event of overt vascular injury.Accumulating evidence also indicates vital roles for platelets in wound repair, the innate immune response, and metastatic tumor cell biology.The average platelet count in humans ranges from 150 × 10 9 to 400 × 10 9 per liter, although the level for any individual is maintained within fairly narrow limits from day to day.While 150 × 10 9 to 400 × 10 9 per liter is considered "normal," the values derived from the mean ± 2 SDs of a group of "healthy" individuals, epidemiological evidence indicates that individuals who display platelet counts in the highest quartile of the normal range have a 2-fold increased risk of adverse cardiovascular events (1), and, in both experimental animal models of metastatic cancer and patients with tumors, higher platelet levels carry an unfavorable prognosis (2).With a lifespan of approximately 10 days, a blood volume of 5 liters, and one-third of platelets pooled in the spleen, the average adult must produce each day approximately 1 × 10 11 platelets to maintain a normal platelet count under steady-state conditions, a level of production that can increase more than 10-fold under conditions of increased demand.The primary regulator of platelet production is thrombopoietin, an acidic glycoprotein produced primarily in the liver, kidney, and BM.The biochemistry and structure-activity relationships of thrombopoietin have been carefully evaluated, as have the binding sites to its receptor, the product of the cellular protooncogene c-Mpl (3, 4).This Review will focus on the regulation of platelet production, how thrombopoietin stimulates thrombopoiesis under normal and pathological conditions, and the molecular mechanisms through which the hormone produces its biological effects.In addition to providing an understanding of normal physiology, the discovery of the biological effects of thrombopoietin and its receptor provides a platform on which to understand a number of clinical disorders of hematopoiesis and serves to suggest novel therapeutic approaches to several diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Ihle, J. N. (1995) · Nature · doi:10.1038/377591a0 · Cited by 1,203
Avecilla, S. T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., Jin, D. K., Dias, S., Zhang, F., Hartman, T. E., et al. (2004) · Nature Medicine · doi:10.1038/nm973 · Cited by 790
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F. A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., et al. (2001) · Blood · doi:10.1182/blood.v98.9.2720 · Cited by 667
Thrombopoietin: the primary regulator of platelet production [see comments]
Kaushansky, K. (1995) · Blood · doi:10.1182/blood.v86.2.419.bloodjournal862419 · Cited by 642
Self-citationIdentification of an Acquired JAK2 Mutation in Polycythemia Vera
Zhao, R., Xing, S., Li, Z., Fu, X., Li, Q., Krantz, S. B., & Zhao, Z. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500138200 · Cited by 615
Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., & Wilson, I. A. (1999) · Science · doi:10.1126/science.283.5404.987 · Cited by 599
Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G., & Humphries, R. K. (1998) · Genes & Development · doi:10.1101/gad.12.11.1610 · Cited by 556
Vigon, I., Mornon, J. P., Cocault, L., Mitjavila, M. T., Tambourin, P., Gisselbrecht, S., & Souyri, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5640 · Cited by 509
Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459
Thaulow, E., Erikssen, J., Sandvik, L., Stormorken, H., & Cohn, P. F. (1991) · Circulation · doi:10.1161/01.cir.84.2.613 · Cited by 458
Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
Wo Tsui, H., Siminovitch, K. A., de Souza, L., & Tsui, F. W. L. (1993) · Nature Genetics · doi:10.1038/ng0693-124 · Cited by 441
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P., & Burstein, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5953 · Cited by 407
Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin
Kimura, S., Roberts, A. W., Metcalf, D., & Alexander, W. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1195 · Cited by 391
Broudy, V., Lin, N., & Kaushansky, K. (1995) · Blood · doi:10.1182/blood.v85.7.1719.bloodjournal8571719 · Cited by 390
Self-citationSouyri, M., Vigon, I., Penciolelli, J.-F., Heard, J.-M., Tambourin, P., & Wendling, F. (1990) · Cell · doi:10.1016/0092-8674(90)90410-g · Cited by 388
Kuter, D., & Rosenberg, R. (1995) · Blood · doi:10.1182/blood.v85.10.2720.bloodjournal85102720 · Cited by 379
Ding, J., Komatsu, H., Wakita, A., Kato-Uranishi, M., Ito, M., Satoh, A., Tsuboi, K., Nitta, M., Miyazaki, H., Iida, S., et al. (2004) · Blood · doi:10.1182/blood-2003-10-3471 · Cited by 373
Role of c-mpl in Early Hematopoiesis
Solar, G. P., Kerr, W. G., Zeigler, F. C., Hess, D., Donahue, C., de Sauvage, F. J., & Eaton, D. L. (1998) · Blood · doi:10.1182/blood.v92.1.4.413k38_4_10 · Cited by 367
Nerlov, C., Querfurth, E., Kulessa, H., & Graf, T. (2000) · Blood · doi:10.1182/blood.v95.8.2543 · Cited by 366
c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
Ballmaier, M., Germeshausen, M., Schulze, H., Cherkaoui, K., Lang, S., Gaudig, A., Krukemeier, S., Eilers, M., Strauß, G., & Welte, K. (2001) · Blood · doi:10.1182/blood.v97.1.139 · Cited by 356
Sitnicka, E., Lin, N., Priestley, G., Fox, N., Broudy, V., Wolf, N., & Kaushansky, K. (1996) · Blood · doi:10.1182/blood.v87.12.4998.bloodjournal87124998 · Cited by 350
Self-citationMethia, N., Louache, F., Vainchenker, W., & Wendling, F. (1993) · Blood · doi:10.1182/blood.v82.5.1395.1395 · Cited by 350
Kaushansky, K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391107 · Cited by 325
Self-citationThrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.
Kaushansky, K., Broudy, V. C., Lin, N., Jorgensen, M. J., McCarty, J., Fox, N., Zucker-Franklin, D., & Lofton-Day, C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3234 · Cited by 313
Self-citationConstraints on reinitiation of translation in mammals
Kozak, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.24.5226 · Cited by 303
Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera
Moliterno, A. R., Hankins, W. D., & Spivak, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380903 · Cited by 302
Huang, L. J.-S., Constantinescu, S. N., & Lodish, H. F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00401-4 · Cited by 294
Sungaran, R., Markovic, B., & Chong, B. H. (1997) · Blood · doi:10.1182/blood.v89.1.101 · Cited by 292
Low levels of erythroid and myeloid progenitors in thrombopoietin-and c- mpl-deficient mice
Carver-Moore, K., Broxmeyer, H., Luoh, S., Cooper, S., Peng, J., Burstein, S., Moore, M., & de Sauvage, F. (1996) · Blood · doi:10.1182/blood.v88.3.803.803 · Cited by 280
Griesshammer, M., Bangerter, M., Sauer, T., Wennauer, R., Bergmann, L., & Heimpel, H. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00452.x · Cited by 276
Chan, I. T., Kutok, J. L., Williams, I. R., Cohen, S., Kelly, L., Shigematsu, H., Johnson, L., Akashi, K., Tuveson, D. A., Jacks, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20476 · Cited by 270
Macrophages specifically regulate the concentration of their own growth factor in the circulation.
Bartocci, A., Mastrogiannis, D. S., Migliorati, G., Stockert, R. J., Wolkoff, A. W., & Stanley, E. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6179 · Cited by 267
Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb
Emambokus, N. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg434 · Cited by 259
Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia
Ihara, K., Ishii, E., Eguchi, M., Takada, H., Suminoe, A., Good, R. A., & Hara, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3132 · Cited by 255
Hamada, T., Möhle, R., Hesselgesser, J., Hoxie, J., Nachman, R. L., Moore, M. A. S., & Rafii, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.539 · Cited by 243
Expression of Bcl-x in Erythroid Precursors from Patients with Polycythemia Vera
Silva, M., Richard, C., Benito, A., Sanz, C., Olalla, I., & Fernández-Luna, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380902 · Cited by 229
Translational pathophysiology: a novel molecular mechanism of human disease
Cazzola, M., & Skoda, R. C. (2000) · Blood · doi:10.1182/blood.v95.11.3280 · Cited by 223
Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase Domain
Saharinen, P., Vihinen, M., & Silvennoinen, O. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-06-0342 · Cited by 216
Rojnuckarin, P., Drachman, J. G., & Kaushansky, K. (1999) · Blood · doi:10.1182/blood.v94.4.1273 · Cited by 215
Self-citationCirculating thrombopoietin level in chronic immune thrombocytopenic purpura
KOSUGI, S., KURATA, Y., T OMIYAMA, Y., T AHARA, T., KATO, T., TADOKORO, S., SHIRAGA, M., H ONDA, S., KANAKURA, Y., & MATSUZAWA, Y. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1702.x · Cited by 214
The Origin and Nature of the Blood Plates
WRIGHT, J. H. (1906) · The Boston Medical and Surgical Journal · doi:10.1056/nejm190606071542301 · Cited by 206
Yan, X., Lacey, D., Hill, D., Chen, Y., Fletcher, F., Hawley, R., & McNiece, I. (1996) · Blood · doi:10.1182/blood.v88.2.402.bloodjournal882402 · Cited by 202
Kobayashi, M., Laver, J., Kato, T., Miyazaki, H., & Ogawa, M. (1996) · Blood · doi:10.1182/blood.v88.2.429.bloodjournal882429 · Cited by 196
Thrombopoietin Signal Transduction in Purified Murine Megakaryocytes
Drachman, J. G., Sabath, D. F., Fox, N. E., & Kaushansky, K. (1997) · Blood · doi:10.1182/blood.v89.2.483 · Cited by 183
Self-citationLindauer, K., Loerting, T., Liedl, K. R., & Kroemer, R. T. (2001) · Protein Engineering, Design and Selection · doi:10.1093/protein/14.1.27 · Cited by 182
Li, J., Xia, Y., & Kuter, D. J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01571.x · Cited by 164
Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.
Zanjani, E. D., Lutton, J. D., Hoffman, R., & Wasserman, L. R. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108706 · Cited by 161
Chronic Myeloproliferative Disorders
Spivak, J. L., Barosi, G., Tognoni, G., Barbui, T., Finazzi, G., Marchioli, R., & Marchetti, M. (2003) · Hematology · doi:10.1182/asheducation-2003.1.200 · Cited by 155
Dai, C., Krantz, S. B., Dessypris, E., Means, R. T., Horn, S., & Gilbert, H. S. (1992) · Blood · doi:10.1182/blood.v80.4.891.891 · Cited by 139
Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis
Moliterno, A. R., Williams, D. M., Gutierrez‐Alamillo, L., Salvatori, R., Ingersoll, R., & Spivak, J. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404241101 · Cited by 139
Thrombopoietin Signal Transduction Requires Functional JAK2, Not TYK2
Drachman, J. G., Millett, K. M., & Kaushansky, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13480 · Cited by 136
Self-citationKirito, K., Fox, N. E., & Kaushansky, K. (2003) · Blood · doi:10.1182/blood-2003-03-0944 · Cited by 136
Self-citationvan den Oudenrijn, S., Bruin, M. C. A., Folman, C. C., Peters, M., Faulkner, L., de Haas, M., & Borne, A. E. G. K. V. D. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02175.x · Cited by 133
Hodohara, K., Fujii, N., Yamamoto, N., & Kaushansky, K. (2000) · Blood · doi:10.1182/blood.v95.3.769.003a49_769_775 · Cited by 132
Self-citationHuman Platelets Display High-Affinity Receptors for Thrombopoietin
Broudy, V. C., Lin, N. L., Sabath, D. F., Papayannopoulou, T., & Kaushansky, K. (1997) · Blood · doi:10.1182/blood.v89.6.1896 · Cited by 131
Self-citationRegulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin
Chen, J., Herceg-Harjacek, L., Groopman, J., & Grabarek, J. (1995) · Blood · doi:10.1182/blood.v86.11.4054.bloodjournal86114054 · Cited by 130
Thrombopoietin levels in patients with primary and reactive thrombocytosis
Cerutti, A., Custodi, P., Duranti, M., Noris, P., & Balduini, C. L. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3823196.x · Cited by 130
Miyakawa, Y., Rojnuckarin, P., Habib, T., & Kaushansky, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002633200 · Cited by 127
Self-citationThrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists
Oda, A., Miyakawa, Y., Druker, B. J., Ozaki, K., Yabusaki, K., Shirasawa, Y., Handa, M., Kato, T., Miyazaki, H., Shimosaka, A., et al. (1996) · Blood · doi:10.1182/blood.v87.11.4664.bloodjournal87114664 · Cited by 119
Axelrad, A. A., Eskinazi, D., Correa, P. N., & Amato, D. (2000) · Blood · doi:10.1182/blood.v96.10.3310 · Cited by 117
Ichikawa, N., Ishida, F., Shimodaira, S., Tahara, T., Kato, T., & Kitano, K. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650545 · Cited by 93
STAT3 is constitutively active in some patients with Polycythemia rubra vera
Röder, S., Steimle, C., Meinhardt, G., & Pahl, H. L. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00637-3 · Cited by 93
Geddis, A. E., Fox, N. E., & Kaushansky, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105178200 · Cited by 90
Self-citationSungaran, R., Chisholm, O., Markovic, B., Khachigian, L. M., Tanaka, Y., & Chong, B. H. (2000) · Blood · doi:10.1182/blood.v95.10.3094 · Cited by 88
Hsu, H., Tsai, W., Jiang, M.-L., Ho, C.-H., Hsu, M., Ho, C., & Wang, S. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90154-3 · Cited by 84
Sabath, D. F., Kaushansky, K., & Broudy, V. C. (1999) · Blood · doi:10.1182/blood.v94.1.365.413a46_365_367 · Cited by 79
Self-citationGainsford, T., Nandurkar, H., Metcalf, D., Robb, L., Begley, C., & Alexander, W. (2000) · Blood · doi:10.1182/blood.v95.2.528 · Cited by 75
Hepatic Thrombopoietin mRNA Is Increased in Acute Inflammation
Fandrey, J., Frackowski, U., Jelkmann, W., & Wolber, E.-M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616745 · Cited by 69
Gainsford, T., Roberts, A. W., Kimura, S. H., Metcalf, D., Dranoff, G., Mulligan, R. C., Begley, C. G., Robb, L. G., & Alexander, W. S. (1998) · Blood · doi:10.1182/blood.v91.8.2745.2745_2745_2752 · Cited by 63
Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene
Metcalf, D., Carpinelli, M. R., Hyland, C. D., Mifsud, S., DiRago, L., Nicola, N. A., Hilton, D. J., & Alexander, W. S. (2005) · Blood · doi:10.1182/blood-2004-12-4806 · Cited by 61
Javed, M. J., Richmond, T. D., & Barber, D. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00063-2 · Cited by 61
Dai, C., Chung, I., & Krantz, S. B. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.10.017 · Cited by 57
Shinjo, K., Takeshita, A., Nakamura, S., Naitoh, K., Yanagi, M., Tobita, T., Ohnishi, K., & Ohno, R. (1998) · Leukemia · doi:10.1038/sj.leu.2400946 · Cited by 56
Engagement of integrin α4β1 enhances thrombopoietin-induced megakaryopoiesis
Fox, N. E., & Kaushansky, K. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.10.002 · Cited by 47
Self-citationNative thrombopoietin: Structure and function
Kato, T., Matsumoto, A., Ogami, K., Tahara, T., Morita, H., & Miyazaki, H. (1998) · Stem Cells · doi:10.1002/stem.5530160704 · Cited by 47
Role of Gab proteins in phosphatidylinositol 3-kinase activation by thrombopoietin (Tpo)
Bouscary, D., Lecoq‐Lafon, C., Chrétien, S., Zompì, S., Fichelson, S., Muller, O., Porteu, F., Dusanter‐Fourt, I., Gisselbrecht, S., Mayeux, P., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204317 · Cited by 47
Native Thrombopoietin: Structure and Function
Kato, T., Matsumoto, A., Ogami, K., Tahara, T., Morita, H., & Miyazaki, H. (1998) · Stem Cells · doi:10.1002/stem.160322 · Cited by 43
McDonald, T. P. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb00196.x · Cited by 42
Gitler, A. D., Kong, Y., Choi, J. K., Zhu, Y., Pear, W. S., & Epstein, J. A. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000113462.98851.2e · Cited by 42
Endogenous thrombopoietin serum levels during multicycle chemotherapy
Engel, C., Loeffler, M., FRANKE, H., & Schmitz, S. H. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01459.x · Cited by 35
Rojnuckarin, P., Miyakawa, Y., Fox, N. E., Deou, J., Daum, G., & Kaushansky, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106508200 · Cited by 33
Self-citationSosman, J. A., Aronson, F. R., Sznol, M., Atkins, M. B., Dutcher, J. P., Weiss, G. R., ISAACS, R. E., Margolin, K. A., Fisher, R. I., Ernest, M. L., et al. (1997) · PubMed · Cited by 30
Li, J., Sabath, D. F., & Kuter, D. J. (2000) · Cytokine · doi:10.1006/cyto.1999.0654 · Cited by 28
Is thrombopoietin interleukin 6?
Williams, N. (1991) · PubMed · Cited by 25
IL‐3 does not contribute to platelet production in c‐Mpl‐deficient mice
Chen, Q., de Sauvage, F. J., Solar, G. P., & Eaton, D. (1998) · Stem Cells · doi:10.1002/stem.5530160706 · Cited by 18
Jagerschmidt, A., Fleury, V., Anger, M., Thomas, C., Agnel, M., & O'Brien, D. P. (1998) · Biochemical Journal · doi:10.1042/bj3330729 · Cited by 17
Millot, G. A., Féger, F., Garçon, L., Vainchenker, W., Dumènil, D., & Svinarchuk, F. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00776-7 · Cited by 15
Cited by
Programmed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031
Thrombosis formation on atherosclerotic lesions and plaque rupture
Badimon, L., & Vilahur, G. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12296 · Cited by 697
The biogenesis of platelets from megakaryocyte proplatelets
Patel, S. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26891 · Cited by 603
Endoreplication: polyploidy with purpose
Lee, H. O., Davidson, J. M., & Duronio, R. J. (2009) · Genes & Development · doi:10.1101/gad.1829209 · Cited by 590
Korniluk, A., Koper-Lenkiewicz, O. M., Kamińska, J., Kemona, H., & Dymicka-Piekarska, V. (2019) · Mediators of Inflammation · doi:10.1155/2019/9213074 · Cited by 577
Metadata
- Authors
- Kaushansky, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-12-01
- Volume
- 115
- Issue
- 12
- Pages
- 3339-3347
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2017955228
- Cited by
- 570
- References
- 91
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.